Instil Bio, Inc.
TILCIK 0001789769
Revenue (TTM)
$52K
−100.0% YoY
Q1 May 2026
Net Income (TTM)
−$67.39M
+3.7% YoY
Q1 May 2026
EPS Diluted (TTM)
−$10.19
+6.1% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-146,219.2%
Q1 May 2026
Net Margin
-129,586.5%
Q1 May 2026
Free Cash Flow (TTM)
−$92.42M
Q1 May 2026
Cash
$5.02M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
6.78M sh
Q1 May 2026